"Whilst moves from management may have been slower than any of us would like, I believe it is a strong team and DB is a proven strategist. The worst thing that a management team could do is make rash decisions to appease shareholders so they have to bear the criticisms over the years on HC and the like before they announce a strategic decision, the share price goes through the roof and everyone says what a fantastic job they've done.Patience is hard when we all want to see instant return on our investment but in the case of A2M I see very little risk which is far more important. It's worth management spending the time (even if that is a number of years) to ensure the market sees long term growth and adjusts valuations accordingly."
Yea and how much time do you expect they should have? been nearly 4 years and SP still in dumps (dropped again significantly yesterday too on no reason) while other companies (BEGA, Fonterra etc) have recovered and made gains in that time. At 6 mill plus and free shares I expect faster work from management. They are still failing to establish a proper strategy to return SP. And yes its only SP that matters here.
I'm sick of people standing up for the trash in charge when so clear bare minimum has been done and now sit back scraping by and handled situations like US baby formula problems, China problems and synlait/bright poorly and a poor buyback decision. How can people criticize anyone who speaks out against management. Shareholders have every right to criticize as SP again is still garbage after nearly 4 years of same tired bs excuses over and over and no solution.
- Forums
- ASX - By Stock
- A2M
- Media Updates
A2M
the a2 milk company limited
Add to My Watchlist
1.67%
!
$7.93

Media Updates, page-15066
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.93 |
Change
0.130(1.67%) |
Mkt cap ! $5.741B |
Open | High | Low | Value | Volume |
$7.87 | $7.99 | $7.71 | $17.74M | 2.261M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 111 | $7.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.96 | 3799 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 111 | 7.930 |
2 | 2969 | 7.910 |
1 | 5534 | 7.870 |
1 | 5534 | 7.860 |
1 | 5534 | 7.850 |
Price($) | Vol. | No. |
---|---|---|
7.960 | 565 | 1 |
7.970 | 5534 | 1 |
7.980 | 20346 | 2 |
7.990 | 19765 | 5 |
8.000 | 11947 | 9 |
Last trade - 16.13pm 27/06/2025 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online